Genetic metabolic polymorphisms and the risk of cancer: A review of the literature

Biomarkers

Volumn 1, Issue 3, 1996, Pages 149-173

  D'Errico, Angelo ^a   Taioli, Emanuela ^a,b,c   Chen, Xiang ^a   Vineis, Paolo ^d  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c NEW YORK UNIVERSITY   (United States)

^d MOLINETTE HOSPITAL   (Italy)

Author keywords

AHH; Cancer; Cancer susceptibility genes; CYP1A1; CYP2D6; GSTM1; Metabolic polymorphisms; NAT2

Indexed keywords

EID: 0001360416     PISSN: 1354750X     EISSN: None     Source Type: Journal    
DOI: 10.3109/13547509609079352     Document Type: Review

References (123)

1. ABE, S., MAKIMURA, S., OGURA, S. AND NAKAJIMA, Y. (1990) Pulmonary drug-metabolizing enzyme in alveolar macrophages in relation to cigarette smoking. Japanese Journal of Medicine, 29, 164-167.
2. AGUNDEZ, J. A. G., MARTINEZ, C., LADERO, J. M., LEDESMA, M. C., RAMOS, J. M., MARTIN, R., RODRIQUEZ, A., JARA, C. AND BENITEZ, J. (1994) Debrisoquine oxidation genotype and susceptibility to lung cancer. Clinical Pharmacology & Therapeutics, 55, 10-14.
3. AGUNDEZ, J. A. G., LADERO, J. M., OLIVERA, M., ABILDUA, R., ROMAN, J. M. AND BENITEZ, J. (1995) Genetic analysis of the arylamine N-acetyltransferase polymorphism in breast cancer patients. Oncology, 52, 7-11.
4. ALEXANDRIE, A. K., INGELMAN-SUNDBERG, M., SEIDEGARD, J., TORNLING, G. AND RANNUG, A. (1994) Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: a study on host factors in relation to age at onset, gender and histological cancer types. Carcinogenesis, 15, 1785-1790.
5. AMBROSONE, C. B., FREUDENHEIM, J. L., GRAHAM, S., MARSHALL, J. R., VENA, J. E., BRASURE, J. E., LAUGHLIN, R., NEMOTO, T., MICHALEK, A. M., HARRINGTON, A., FORD, T. D. AND SHIELDS, P. G. (1995) Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk. Cancer Research, 55, 3483-3485.
6. AMOS, C. I., CAPORASO, N. E. AND WESTON, A. (1992) Host factors in lung cancer risk: a review of interdisciplinary studies. Cancer Epidemiology, Biomarkers and Prevention, 1, 505-513.
7. AYESH, R., IDLE, J. R., RITCHIE, J. C., CROTHERS, M. J. AND HETZEL, M. R. (1984) Metabolic oxidation phenotypes as markers for susceptibility to lung cancer. Nature, 312, 169-170.
8. BELL, D. A., TAYLOR, J. A., PAULSON, D. F., ROBERTSON, C. N., MOHLER, J. L. AND LUCIER, G. W. (1993) Genetic risk and carcinogenesis exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. Journal of the National Cancer Institute, 85, 1159-1164.
9. BENITEZ, J., LADERO, J. M., FERNANDEZ-GUNDIN, M. J., LLERENA, A., COBALEDA, J., MARTINEZ, C., MUNOZ, J. J., VARGAS, E., PRADOS, J., GONZALEZ-ROZAS, F., RODRIGUEZ-MOLINA, J. AND USON, A. C. (1990) Polymorphic oxidation of debrisoquine in bladder cancer. Annals of Medicine, 22, 157-160.
10. BENITEZ, J., LADERO, J. M., JARA, C., CARRILLO, J. A., COBALEDA, J., LLERENA, A., VARGAS, E. AND MUNOZ, J. J. (1991) Polymorphic oxidation of debrisoquine in lung cancer patients. European Journal of Cancer, 27, 158-161.
11. BOARD, P., COGGAN, M., JOHNSTON, P., ROSS, V. AND SUZUKI, T. G. W. (1990) Genetic heterogeneity of the human glutathione transferase: a complex of gene families. Pharmacological Therapy, 48, 357-369.
12. BROCKMOLLER, J., KERB, R., DRAKOULIS, N., NITZ, M. AND ROOTS, I. (1993) Genotype and phenotype of glutathione S-transferase Class μ and ψ in lung cancer patients and controls. Cancer Research, 53, 1004-1011.
13. BROCKMOLLER, J., KERB, R., DRAKOULIS, N., STAFFELDT, B. AND ROOTS, I. (1994) Glutathione S-transferase M1 and its variants A and B as host factors of bladder cancer susceptibility: a case-control study. Cancer Research, 54, 4103-4111.
14. BROSEN, K., GRAM, L. F., HAGHFELT, T. AND BERTLISSON, L. (1987) Extensive metabolizers of debrisoquine become poor metabolizers during quinidine treatment. Pharmacology and Toxicology, 60, 312-314.
15. BUCHERT, E. T., WOOSLEY, R. L., SWAIN, S. M., OLIVER, S. J. COUGHLIN, S. S., PICKLE, L., TROCK, B. AND RIEGEL, A. T. (1993) Relationship of CYP2D6 (debrisoquine hydroxylase) genotype to breast cancer susceptibility. Pharmacogenetics, 3, 322-327.
16. BULOVSKAYA, L. N., KRUPKIN, R. G., BOCHINA, T. A., SHIPKOVA, A. A. AND PAVLOVA, M. V. (1978) Acetylator phenotype in patients with breast cancer. Oncology, 35, 185-188.
17. BURGESS, E. J. AND TRAFFORD, J. A. P. (1985) Acetylator phenotype in patients with lung carcinoma - a negative report. European Journal of Respiratory Diseases, 67, 17-19.
18. CAPORASO, N., HAYES, R. B., DOSEMECI, M., HOOVER, R., AYESHI, R., HETZEL, M. AND IDLE, J. (1989) Lung cancer risk, occupational exposure, and debrisoquine metabolic phenotype. Cancer Research, 49, 3675-3679.
19. CAPORASO, N., TUCKER, M. A., HOOVER, R. N., HAYES, R. B., PICKLE, L. W., ISSAQ, H. L., MUSCHIK, G. M., GREEN-GALLO, L., BUIVYS, D., AISNER, S., RESAU, J. H., TRUMP, B. F., TOLLERUD, D., WETSON, A. AND HARRIS, C. C. (1990) Lung cancer and debrisoquine metabolic phenotype. Journal of the National Cancer Institute, 82, 1264-1272.
20. CARTWRIGHT, R. A., ROGERS, H. J., BARHAM-HALL, D., GLASHAN, R. W., AHMAD, R. A., HIGGINS, E. AND KAHN, M. A. (1982) Role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer. Lancet, 2, 842-845.
21. CARTWRIGHT, R. A., PHILIP, P. A., ROGERS, H. J. AND GLASHAN, R. W. (1984) Genetically determined debrisoquine oxidation capacity in bladder cancer. Carcinogenesis, 5, 1191-1192.
22. CORNFIELD, J. (1956) A statistical problem arising from retrospective studies. Proceedings of the Third Berkeley Symposium, IV (University of California Press, Berkeley), pp. 133-148.
23. COSMA, G. N., CROFTS, F., CURRIE, D., WIRGIN, I., TONIOLO, P. AND GARTE, S. J. (1993) Racial differences in restriction fragment length polymorphisms and messenger RNA inducibility of the human CYP1A1 gene. Cancer Epidemiology, Biomarkers and Prevention, 2, 53-57.
24. CRESPI, C. L., PENMAN, B. W., GELBOIN, H. V. AND GONZALEZ, F. J. (1991) A tobacco-smoke derived nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human P-450s including the polymorphic cytocrome P-4502D6. Carcinogenesis, 12, 1197-1201.
25. CROFTS, F., COSMA, G., CURRIE, D., TAIOLI, E., TONIOLO, P. AND GARTE, S. J. (1993) A novel CYP1A1 gene polymorphism in African-Americans [published erratum appears in Carcinogensis (1993) 14 (12), 2652]. Carcinogenesis, 14, 1729-1731.
26. CROFTS, F., TAIOLI, E., TRACHMAN, J., COSMA, G. N., CURRIE, D., TONIOLO, P. AND GARTE, S. (1994) Functional significance of different human CYP1A1 genotypes. Carcinogenesis, 15, 2961-2963.
27. DALY, A. K., THOMAS, D. J., COOPER, J., PEARSON, W. R., NEAL, D. E. AND IDLE, J. R. (1993) Homozygous deletion of gene for glutathione S-transferase M1 in bladder cancer. British Medical Journal, 307, 481-482.
28. DUCHE, J. C., JOANNE, C., BARRE, J., DE CREMOUX, H., DALPHIN, J. C., DEPIERRE, A., BROCHARD, P., TILLEMENT, J. P. AND BECHTEL, P. (1991) Lack of a relationship between the polymorphism of debrisoquinone oxidation and lung cancer. British Journal of Clinical Pharmacology, 31, 533-536.
29. EMERY, A. E., ANAND, R., DANDORD, N., DUNCAN, W. AND PATON, L. (1978) Arylhydrocarbon-hydroxylase inducibility in patients with cancer. Lancet, 1, 470-472.
30. EVANS, D. A. P. (1989) N-Acetyltransferase. Pharmacological Therapy, 42, 157-234.
31. EVANS, D. A. P., WHITE, T. A. (1964) Human acetylation polymorphism. Journal of Laboratory and Clinical Medicine, 63, 394-403.
32. EVANS, D. A. P. AND MANLEY, K. A. AND MCKUSICK, V. A. (1960) Genetic control of isoniazid metabolism in man. British Medical Journal, 2, 485-491.
33. FLEISS, J. L., TYTUN, A. AND URAY, H. K. (1980) A simple approximation for calculating sample sizes for comparing independent proportions. Biometrics, 36, 343-346.
34. GAHMBERG, C. G., SEKKI, A., KOSUNEN, T. U., HOLSTI, L. R. AND MAKELA, O. (1979) Induction of aryl hydrocarbon hydroxylase activity and pulmonary carcinoma. International Journal of Cancer, 23, 302-305.
35. GARTE, S. J., TRACHMAN, J., CROFTS, F., TONION, P., BUXBAUM, J., BAYO, S. AND TAIOLI, E. (1996) Distribution of composite CYP1A1 genotypes in African-Americans, Africans and Caucasians. Human Heridity, 46, 121-127.
36. GRANT, D. M. (1993) Molecular genetics of the N-acetyltransferase. Pharmacogenetics, 3, 45-50.
37. GUIRGIS, H. A., LYNCH, H. T., MATE, T., HARRIS, R. E., WELLS, I., CAHA, L., ANDERSON, J., MALONEY, K. AND RANKIN, L. (1976) Aryl-hydrocarbon hydroxylase activity in lymphocytes from lung patients and normal controls. Oncology, 33, 105-198.
38. HAMADA, G. S., SUGIMURA, H., SUZUKI, J., NAGURA, K., KIYOKAWA, E., IWASE, T., TANAKA, M., TAKAHASHI, T., WATANABE, S., KINO, I. AND TSUGANE, S. (1995) The heme-binding region polymorphism of cytochrome P4501A1 (CYP1A1), rather than the Rsal polymorphism of P450IIE1 (CYPIIE1), is associated with lung cancer in Rio de Janeiro. Cancer Epidemiology, Biomarkers and Prevention, 4, 917-918.
39. HANKE, J. AND KRAJEWSKA, B. (1990) Acetylation phenotypes and bladder cancer. Journal of Occupational Medicine, 32, 917-918.
40. HANSSEN, H. P., AGARWAL, D. P., GOEDDE, H. W., BUCHER, H., HULAND, H., BRACHMANN, W. AND OVENBACK, R. (1985) Association of N-acetyltransferase polymorphism and environmental factors with bladder carcinogenesis. Study in a North German population. European Urology, 11, 263-266.
41. HARADA, S., MISAWA, S., NAKAMURA, T., TANAKA, N., UENO, E. AND MUTZUMI, N. (1992) Detection of GST1 gene deletion by polymerase chain reaction and its possible correlation with stomach cancer in Japanese. Human Genetics, 90, 62-64.
42. HAYASHI, S., WATANABE, J. AND KAWAJIRI, K. (1992) High susceptibility to lung cancer analyzed in terms of combined genotypes of CYP1A1 and Mu-class glutathione S-transferase genes. Japanese Journal of Cancer Research, 83, 866-870.
43. HAYES, R. B., BI, W., ROTHMAN, N., BROLY, F., CAPORASO, N., FENG, P., YOU, X., YIN, S., WOOSLEY, R. L. AND MEYER, U. A. (1993) N-acetylation phenotype and genotype and risk of bladder cancer in benzidine-exposed workers. Carcinogenesis, 14, 675-678.
44. HEARSE, D. J. AND WEBER, W. W. (1973) Multiple N-acetyltransferase and drug metabolism. Biochemical Journal, 132, 519-526.
45. HECKBERT, S. R., WEISS, N. S., HORNUNG, S. K., EATON, D. L. AND MOTULSKY, A. G. (1992) Glutathione S-transferase and epoxide hydrolase activity in human leukocytes in relation to risk of lung cancer and other smoking-related cancers. Journal of the National Cancer Institute, 84, 414-422.
46. HEIM, M. H. AND MAYER, U. A. (1991) Genetyc polymorphism of debrisoquine oxidation: restriction fragment analysis and allele-specific amplification of mutant alleles of CYP2D6. Methods in Enzymology, 206, 173-183.
47. HIRVONEN, A., HUSGAFVEL-PURSIAINEN, K., KARJALAINEN, A., ANTTILA, S. AND VAINIO, H. (1992) Point-mutational Mspl and Ile-Val polymorphisms closely linked in the CYP1A1 gene: lack of association with susceptibility to lung cancer in a Finnish study population. Cancer Epidemiology, Biomarkers and Prevention, 1, 485-489.
48. HIRVONEN, A., HUSGAFVEL-PURSIAINEN, K., ANTTILA, S., KARJALAINEN, A., PELKONEN, O. AND VAINIO, H. (1993a) PCR-based CYP2D6 genotyping for Finnish lung cancer patients. Pharmacogenetics, 3, 19-27.
49. HIRVONEN, A., HUSGAFVEL-PURSIAINEN, K., ANTTILA, S., KARJALAINEN, A. AND VAINIO, H. (1993b) Polymorphism in CYP1A1 and CYP2D6 genes: possible association with susceptibility to lung cancer. Environmental Health Perspectives, 3, 109-112.
50. HIRVONEN, A., HUSGAFVEL-PURSIAINEN, K., ANTTILA, S. AND VAINIO, H. (1993c) The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung. Carcinogenesis, 14, 1479-1481.
51. HORAI, Y., FUJITA, K. AND ISHIZAKI, T. (1989) Genetically determined N-acetylation and oxidation capacities in Japanese patients with non-occupational urinary bladder cancer. European Journal of Clinical Pharmacology, 37, 581-587.
52. HORSMANS, Y., DESAGER, J. P. AND HARVENGT, C. (1991) Is there a link between debrisoquine oxidation phenotype and lung cancer susceptibility? Biomedicine & Pharmacotherapy, 45, 359-362.
53. IDLE, J. R., MAHGOUB, A., LANCASTER, R. AND SMITH, R. L. (1978) Hypotensive response to debrisoquine and hydroxylation phenotype. Life Sciences, 22, 979-984.
54. ILETT, K. F., DAVID, B. M., DETCHON, P., CASTLEDEN, W. M. AND KWA, R. (1987) Acetylator phenotype in colorectal carcinoma. Cancer Research, 47, 1466-1469.
55. ILETT, K. F., DETCHON, P., INGRAM, D. AND CASTELDEN, W.M. (1990) Acetylator phenotype is not associated with breast cancer. Cancer Research, 50, 6649-6651.
56. JAISWAL, A. K., GONZALES, F. J. AND NEBERT, D. W. (1985) Human P1-450 gene sequence and correlation of mRNA with genetic differences in benzo[a]pyrene metabolism. Nucleic Acids Research, 13, 4503-4520.
57. KADLUBAR, F. F., BUTLER, M. A., KADERLIK, K. R., CHOU, H. C. AND LANG, N. P. (1992) Polymorphisms for aromatic amine metabolism in humans: relevance for human carcinogenesis. Environmental Health Perspectives, 98, 69-74.
58. KAISARY, A., SMITH, P., JACZQ, E., MCALLISTER, C. B. WILKINSON, G. R., RAY, W. A. AND BRANCH, R. A. (1987) Genetic predisposition to bladder cancer: ability to hydroxylate debrisoquine and mephenytoin as risk factors. Cancer Research, 47, 5488-5493.
59. KARAKAYA, A. E., COK, I., SARDAS, S., GOGUS, O. AND SARDAS, O. S. (1986) N-Acetyltransferase phenotype of patients with bladder cancer. Human Toxicology, 5, 333-335.
60. KARKI, N. T., POKELA, R., NUUTINEN, L. AND PELKONEN, O. (1987) Aryl hydrocarbon hydroxylase in lymphocytes and lung tissue from lung cancer patients and controls. International Journal of Cancer, 39, 565-570.
61. KATOH, T., INATOMI, H., NAGAOKA, A. AND SUGITA, A. (1995) Cytochrome P4501A1 gene polymorphism and homozygous deletion of the glutathione S-transferase M1 gene in urothelial cancer patients. Carcinogenesis, 16, 655-657.
62. KAWAJIRI, K. AND FUJII-KURIYAMA, Y. (1991) P450 and human cancer. Japanese Journal of Cancer Research, 82, 1325-1335.
63. KAWAJIRI, K., NAKACHI, K., IMAI, K., YOSHII, A., SHINODA, N. AND WATANABE, J. (1990) Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P4501A1 gene. FEBS Letters, 263, 131-133.
64. KELLERMAN, G., SHAW, C. R. AND LUYTEN-KELLERMAN, M. (1973) Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma. New England Journal of Medicine, 289, 934-937.
65. KELSEY, K. T., WIENCKE, J. K. AND SPITZ, M. R. (1994) A race-specific genetic polymorphism in the CYP1A1 gene is not associated with lung cancer in African Americans. Carcinogenesis, 15, 1121-1124.
66. KIHARA, M., KIHARA, M. AND NODA, K. (1994) Lung cancer risk of GSTM1 null genotype is dependent on the extent of tobacco smoke exposure. Carcinogenesis, 15, 415-418.
67. KOURI, R. E., MCKINNEY, C. E., SLOMIANY, D. J., SNODGRASS, D. R., WRAY, N. P. AND MCLEMORE, T. L. (1982) Positive correlation between high aryl hydrocarbon hydroxylase activity and primary lung cancer as analysed in cryopreserved lymphocytes. Cancer Research, 42, 5030-5037.
68. LADERO, J. M., KWOK, C. K., JARA, C., FERNANDEZ, L., SILMI, A. M., TAPIA, D. AND USON, A. C. (1985) Hepatic acetylator phenotype in bladder cancer patients. Annals of Clinical Research, 17, 97-99.
69. LADERO, J. M., FERNANDEZ, L., PALMEIRO, R., MUNOZ, J. J., JARA, C., LAZARO, C. AND PEREZ-MANGA, G. (1987) Hepatic acetylation polymorphism in breast cancer patients. Oncology, 44, 341-344.
70. LADERO, J. M., GONZALES, J. F., BENITEZ, J., VARGAS, E., FERNANDEZ, M. J., BAKI, W. AND DIAZ-RUBIO, M. (1991a) Acetylator polymorphism in human colorectal carcinoma. Cancer Research, 51, 2098-2100.
71. LADERO, J. M., BENITEZ, J., JARA, C., LLERENA, A., VALDMELSO, M. J., MUNOZ, J. J. AND VARGAS, E. (1991b) Polymorphic oxidation of debrisoquine in women with breast cancer. Oncology, 48, 107-110.
72. LAFUENTE, A., PUJOL, F., CARRETERO, P., PEREZ VILLA, J. AND CUCHI, A. (1993) Human glutathione S-transferase μ (GSTμ) deficiency as a marker for susceptibility to bladder and larynx cancer among patients. Cancer Letters, 68, 49-54.
73. LANG, N. P., CHU, D. Z. J., HUNTER, C. F., KENDALL, D. C., FLAMMANG, T. J. AND KADLUBAR, F. F. (1986) Role of aromatic amine acetyltransferase in human colorectal cancer. Archives of Surgery, 121, 1259-1261.
74. LAW, M. R., HETZEL, M. R. AND IDLE, J. R. (1989) Debrisoquine metabolism and genetic predisposition to lung cancer. British Journal of Cancer, 59, 686-687.
75. LIN, H. J., HAN, C. Y., BERNSTEIN, D. A., HSIAO, W., LIN, B. K. AND HARDY, S. (1994) Ethnic distribution of the glutathione transferase M1-1 (GSTM1) null genotype in 1473 individuals and application to bladder cancer susceptibility. Carcinogenesis, 15, 1077-1081.
76. LIU, L. AND WANG, L. H. (1988) Correlation between lung prevalence and activities of aryl hydrocarbon hydroxylase and glutathione S-transferase in human lung tissues. Biomedical & Environmental Science, 1, 277-282.
77. LONDON, S. J., DALY, A. K., FAIRBROTHER, K. S., HOLMES, C., CARPENTER, C. L., NAVIDI, W. C. AND IDLE, J. R. (1995) Lung cancer risk in African-Americans in relation to a race-specific CYP1A1 polymorphism. Cancer Research, 55, 6035-6037.
78. LOWER, G. M., NILSSON, T., NELSON, C. E., WOLF, H., GAMSKY, T. E. AND BRYAN, G. T. (1979) N-acetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and Denmark. Environmental Health Perspectives, 29, 71-79.
79. MAHGOUB, A., IDLE, J. R., DRING, L. G., LANCASTER, R. AND SMITH, R. L. (1977) Polymorphic hydroxylation of debrisoquine in man. Lancet, 2, 586-586.
80. MANNERVIK, B. (1985) The isozymes of glutathione S-transferase. Advances in Enzymology 57, 357-417.
81. MCLEMORE, T. L., MARTIN, R. R., BUSBEE, D. L., RITCHIE, R. C., SPRINGER, R. R., TOPPEL, K. L. AND COMTRELL, E. T. (1977) Aryl hydrocarbon hydroxylase activity in pulmonary macrophages and lymphocytes from lung cancer and noncancer patients. Cancer Research, 37, 1175-1181.
82. MCLEMORE, T. L., MARTIN, R. R., WRAY, N. P., CANTRELL, E. T. AND BUSBEE, D. L. (1978) Dissociation between aryl hydrocarbon hydroxylase activity in cultured pulmonary macrophages and blood lymphocytes from lung cancer patients. Cancer Research, 38, 3805-3811.
83. MCLEMORE, T. L., MARTIN, R. R., SPRINGER, R. R., WRAY, N., CANTRELL, E. T. AND BUSBEE, D. L. (1979) Aryl hydrocarbon hydroxylase activity in pulmonary alveolar macrophages and lymphocytes from lung cancer and noncancer patients: a correlation with family histories of cancer. Biochemical Genetics, 17, 795-806.
84. MEYER, C. F., ZANGER, U. M., GRANT, D. AND BLUME, M. (1990) Genetic polymorphism of drug metabolism. Advances in Drug Research, 19, 198.
85. MILLER, M. E. AND COSGRIFF, J. M., (1983) Acetyl phenotype in human bladder cancer. Journal of Urology, 130, 65-66.
86. MOMMSEN, S. AND AAGAARD, J. (1985) N-acetyltransferase phenotypes in the urinary bladder carcinogenesis of a low-risk population. Carcinogenesis, 6, 199-201.
87. NAKACHI, K., IMAI, K., HAYASHI, S., WATANABE, J. AND KAWAJIRI, K. (1991) Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Research, 51, 5177-5180.
88. NAKACHI, K., IMAI, K., HAYASHI, S. AND KAWAJIRI, K. (1983) Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibilty to lung cancer in relation to cigarette dose in a Japanese population. Cancer Research, 53, 2994-2999.
89. NAKAJIMA, T., ELOVAARA, E., ANTTILA, S., HIRVONEN, A., CAMUS, A. M., HAYES, J. D., KETTERE, B. AND VAINIO, H. (1995) Expression and polymorphism of glutathione-S-transferase in human lungs: risk factor in smoking-related cancer. Carcinogenesis, 16, 707-711.
90. NAZAR-STEWART, V., MOTULSKY, A. G., EATON, D. L., WHITE, E., HORNUNG, S. K., LENG, Z. T., STAPLETON, P. AND WEISS, N. S. (1993) The glutathione S-transferase μ polymorphism as a marker for susceptibility to lung carcinoma. Cancer Research, 53, 2313-2318.
91. NEBERT, D. W. AND GONZALEZ, F. J. (1987) P450 genes: structure, evolution and regulation. Annual Review of Biochemistry, 56, 945-993.
92. ODA, Y., TANAKA, M. AND NAKANISHI, I. (1994) Relation between the occurrence of K-ras gene point mutations and genotypes of polymorphic N-acetyltransferase in human colorectal carcinomas. Carcinogenesis, 15, 1365-1369.
93. PETRUZZELLI, S., CAMUS, A. M., CARROZZI, L., GHELARDUCCI, L., RINDI , M., MENCONI, G., ANGELETTI, C. A., AHOTUPA, M., HIETANEN, E., AITIO, A., SARACCI, R., BARTSCH, H. AND GUNTINI, C. (1988) Long-lasting effects of tobacco smoking on pulmonary drug-metabolizing enzyme: a case-control study on lung cancer patients. Cancer Research, 48, 4695-4700.
94. PHILIP, P. A., ROGERS, H. J., MILLS, R. R., RUBENS, R. D. AND CARTWRIGHT, R. A. (1987) Acetylator status and its relationship to breast cancer and other diseases of the breast. European Journal of Cancer & Clinical Oncology, 23, 1701-1706.
95. PHILIP, P. A., FITGERALD, D. L., CARTWRIGHT, R. A., PEAKE, M. D. AND ROGERS, H. J. (1988) Polymorphic N-acetylation capacity in lung cancer. Carcinogenesis, 9, 491-493.
96. REBBECK, T. R., ROSVOLD, E. A., DUGGAN, D. J., ZHANG, J. AND BUETOW, K. H. (1994) Genetics of CYP1A1: coamplification of specific alleles by polymerase chain reaction and association with breast cancer. Cancer Epidemiology, Biomarkers and Prevention, 3, 511-514.
97. RISCH, A., WALLACE, D. M. A., BATHERS, S. AND SIM, E. (1995) Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer. Human Molecular Genetics, 4, 231-236.
98. ROOTS, I., DRAKOULIS, N., PLOCH, M., HEINEMEYER, G., LODDENKEMPER, R., MINKS, T., NITZ, M., OTTE, F. AND KOCH, M. (1988) Debrisoquine hydroxylation phenotype, acetylation phenotype, and ABO blood groups as genetic host factors of lung cancer risk. Klinische Wochenschrift, 66, suppl. XI, 87-97.
99. ROTHMAN, N., STEWART, W. F., CAPORASO, N. E. AND HAYES, R. B. (1993) Misclassification of genetic susceptibility biomarkers: implication for case-control studies and cross-population comparison. Cancer Epidemiology, Biomarkers and Prevention, 2, 299-303.
100. SEIDEGARD, J. AND PERO, R. W. (1985) The hereditary transmission of high glutathione transferase activity towards trans-stilbene oxide in human mononuclear leukocytes. Human Genetics, 69, 66-68.
101. SEIDEGARD, J., PERO, R. W., MILLER, D. G. AND BEATTIE, E. J. (1986) A glutathione transferase in human leukocytes as a marker for the susceptibility to lung cancer. Carcinogenesis, 7, 751-753.
102. SEIDEGARD, J., PERO, R. W., MARKOVITZ, M. M., ROUSH, G., MILLER, D. G. AND BEATTIE, E. J. (1990) Isoenzyme(s) of glutathione transferase (class Mu) as a marker for the susceptibility to lung cancer: a follow up study. Carcinogenesis, 11, 33-36.
103. SEIDEGARD, J., DE PIERRE, J., BIRBERG, W., PILOTTI, A. AND PERO, R. W. (1984) Characterization of soluble glutathione transferase activity in restin mononuclear leukocytes from human blood. Biochemistry and Pharmacology, 33, 3053-3058.
104. SHAW, G. I., FALK, R. T., DESLAURIERS, J., FRAME, J. N., NESBITT, J. C., PASSS, H. I., ISSAQ, H. J., HOOVER, R. N. AND TUCKER, M. A. (1995) Debrisoquine metabolism and lung cancer risk. Cancer Epidemiology, Biomarkers and Prevention, 4, 41-48.
105. SHIBUTA, K., NAKASHIMA, T., ABE, M., MASHIMO, M., MORI, M., UEO, H., AKIYOSHI, T., SUGIMACHI, K. AND SUZUKI, T. (1994) Molecular genotyping for N-acetylation polymorphism in Japanese patients with colorectal cancer. Cancer, 74, 3108-3112.
106. SHIELDS, P. G., CAPORASO, N. E., FALK, R. T., SUGIMURA, H., TRIVERS, G. E., TRUMP, B. F., HOOVER, R. N., WESTON, A. AND HARRIS, C. C. (1993) Lung cancer, race, and a CYP1A1 genetic polymorphism. Cancer Epidemiology, Biomarkers and Prevention, 2, 481-485.
107. SIVARAMAN, L., LEATHAM, M. P., YEE, J., WILKENS, L. R., LAU, A. F. AND LE MARCHAND, L. (1994) CYP1A1 genetic polymorphisms and in situ colorectal cancer. Cancer Research, 54, 3692-3695.
108. STRANGE, R. C., MATHAROO, B., FAULDER, G. C., JONES, P., COTTON, W., ELDER, J. B. AND DEAKIN, M. (1991) The human glutathione S-transferase: a case-control study of the incidence of the GST1 0 phenotype in patients with adenocarcinoma. Carcinogenesis, 12, 25-28.
109. SUGIMURA, H., CAPORASO, N. E., SHAW, G. L., MODALI, R. V., GONZALEZ, F. J., HOOVER, R. N., RESAU, J. H., TRUMP, B. F., WESTON, A. AND HARRIS, C. C. (1990) Human debrisoquine hydroxylase gene polymorphism in cancer patients and controls. Carcinogenesis, 11, 1527-1530.
110. SUGIMARA, H., SUZUKI, I., HAMADA, G. S., IWASE, T., TAKAHASHI, T., NAGURA, K., IWATA, H., WATANABE, S., KINO, I. AND TSUGANE, S. (1994) Cytochrome P-450 1A1 genotype in lung cancer patients and controls in Rio de Janeiro, Brazil. Cancer Epidemiology, Biomarkers and Prevention, 3, 145-148.
111. TAIOLI, E., TRACHMAN, J., CHEN, X., TONIOLO, P. AND GARTE, S. J. (1995a) A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women. Cancer Research, 55, 3757-3758.
112. TAIOLI, E., CROFTS, F., TRACHMAN, J., DEMOPOULOS, R., TONIOLO, P. AND GARTE, S. J. (1995b) A specific African-American CYP1A1 polymorphism is associated with adenocarcinoma of the lung. Cancer Research, 55, 472-473.
113. TEFRE, T., RYBERG, D., HAUGEN, A., NEBERT, D. W., SKAUG, V., BROGGER, A. AND BORRESEN, A. L. (1991) Human CYP1A1 (cytochrome P(1)450) gene: lack of association between the Msp I restriction fragment length polymorphism and incidence of lung cancer in a Norwegian population. Pharmacogenetics, 1, 20-5.
114. TEFRE, T., DALY, A. K., ARMSTRONG, M., LEATHART, J. B. S., IDLE, J. R., BROGGER, A. AND BORRESEN, A. (1994) Genotyping of the CYP2D6 gene in Norwegian lung cancer patients and controls. Pharmacogenetics, 4, 47-57.
115. VATSIS, K. P. AND WEBER, W. W. (1993) Structural heterogeneity of Caucasian N-acetyltransferase at the NAT1 gene locus. Archives of Biochemistry and Biophysics, 301, 71-76.
116. WARHOLM, M., GUTHENBERG, C., MANNERVIK, B. AND VON BAHR, C (1981) Purification of a new glutathione S-transferase (transferase μ) from human liver having high activity with benzo(a)pyrene-4,5-oxide. Biochemical and Biophysical Research Communications, 98, 512-519.
117. WEBSTER, D. J. T., FLOOK, D., JENKINS, J., HUTCHINGS, A. AND ROUTLEDGE, P. A. (1989) Drug acetylation in breast cancer. British Journal of Cancer, 60, 236-237.
118. WOHLLEB, J. C., HUNTER, C. F., BLASS, B., KADLUBAR, F. F., CHU, D. Z. J. AND LANG, N. P. (1990) Aromatic amines acetyltransferase as a marker for colorectal cancer: environmental and demographic associations. International Journal of Cancer, 46, 22-30.
119. WOLF, C. R. (1986) Cytochrome P450s: a multigene family involved in carcinogen metabolism. Trends in Genetics, 2, 209-214.
120. WOLF, C. R. DALE SMITH, C. A., GOUGH, A. C., MOSS, J. E., VALLIS, K. A., HOWARD, G., CAREY, F. J., MILLS, K., MCNEE, W., CARMICHAEL, J. AND SPURR, N. K. (1992) Relationship between debrisoquine hydroxylase polymorphism and cancer susceptibility. Carcinogenesis, 13, 1035-1038.
121. YOSHIKAWA, M., ARASHIDANI, K., KAWAMOTO, T. AND KODAMA, Y. (1994) Aryl hydrocarbon hydroxylase activity in human lung tissue: in relation to cigarette smoking and lung cancer. Environmental Research, 65, 1-11.
122. ZHONG, S., HOWIE, A. F., KETTERER, B., TAYLOR, J., HAYES, J. D., BECKETT, G. J., WATHEN, C. G., WOLF, C. R. AND SPURR, N. K. (1991) Glutathione transferase mu locus: use of genotyping and phenotyping assays to assess association with lung cancer susceptibility. Carcinogenesis, 12, 1553-1537.
123. ZHONG, S., WYLLIE, A. H., BARNES, D., WOLF, C. R. AND SPURR, N. K. (1993) Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis, 14, 1821-1824.